IL32 is progressively expressed in mycosis fungoides independent of helper T-cell 2 and helper T-cell 9 polarization. 2014

Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
Laboratory for Investigative Dermatology, The Rockefeller University, New York, New York.

Mycosis fungoides, the most common type of cutaneous T-cell lymphoma (CTCL), is characterized by a helper T-cell 2 (Th2) skewing with a mature CD4(+) memory T-cell phenotype. Using skin samples from patients with mycosis fungoides (n = 21), healthy volunteers (n = 17), and individuals with atopic dermatitis (n = 17) and psoriasis (n = 9), we found IL32 mRNA expression significantly higher in mycosis fungoides samples than in samples from benign inflammatory skin diseases, and its expression increases with disease progression. By IHC and immunofluorescence, we confirmed IL32 protein expression in many CD3(+)CD4(+) T cells and some epidermotropic T cells in mycosis fungoides lesions. MyLa cells (a mycosis fungoides cell line) express IL32, which, in turn, could promote cellular proliferation and viability in a dose-dependent fashion. IL32-treated MyLa and CTCL HH cells upregulated cell proliferation and survival genes. Of the major "polarizing" T-cell cytokines, only IFNγ mRNA increases with mycosis fungoides progression and positively correlates with IL32 mRNA expression. Th2 cytokines do not positively correlate with IL32 mRNA expression or mycosis fungoides progression. Furthermore, by flow cytometry, IL32 production by circulating activated T cells in healthy individuals was found in both IFNγ(+) and IFNγ(-) cells but not in IL4(+) or IL13(+) cells. In conclusion, we have identified IL32(+) cells as the likely tumor cells in mycosis fungoides, and demonstrated that IL32 mRNA expression increases with mycosis fungoides progression and is significantly higher than mRNA expression in other skin diseases, and that some IL32(+) T cells are independent from the defined Th subsets. Thus, IL32 may play a unique role in mycosis fungoides progression as an autocrine cytokine.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D007378 Interleukins Soluble factors which stimulate growth-related activities of leukocytes as well as other cell types. They enhance cell proliferation and differentiation, DNA synthesis, secretion of other biologically active molecules and responses to immune and inflammatory stimuli. Interleukin
D009182 Mycosis Fungoides A chronic, malignant T-cell lymphoma of the skin. In the late stages, the LYMPH NODES and viscera are affected.
D011565 Psoriasis A common genetically determined, chronic, inflammatory skin disease characterized by rounded erythematous, dry, scaling patches. The lesions have a predilection for nails, scalp, genitalia, extensor surfaces, and the lumbosacral region. Accelerated epidermopoiesis is considered to be the fundamental pathologic feature in psoriasis. Palmoplantaris Pustulosis,Pustular Psoriasis of Palms and Soles,Pustulosis Palmaris et Plantaris,Pustulosis of Palms and Soles,Psoriases
D003876 Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. Eczema, Atopic,Eczema, Infantile,Neurodermatitis, Atopic,Neurodermatitis, Disseminated,Atopic Dermatitis,Atopic Eczema,Atopic Neurodermatitis,Disseminated Neurodermatitis,Infantile Eczema
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D012867 Skin The outer covering of the body that protects it from the environment. It is composed of the DERMIS and the EPIDERMIS.
D012878 Skin Neoplasms Tumors or cancer of the SKIN. Cancer of Skin,Skin Cancer,Cancer of the Skin,Neoplasms, Skin,Cancer, Skin,Cancers, Skin,Neoplasm, Skin,Skin Cancers,Skin Neoplasm

Related Publications

Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
February 1987, Archives of dermatology,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
March 2001, American journal of clinical pathology,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
January 2013, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
February 2022, Dermatopathology (Basel, Switzerland),
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
October 2021, Acta dermato-venereologica,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
April 2022, Clinical and experimental dermatology,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
September 2000, The Journal of investigative dermatology,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
January 2000, The Journal of investigative dermatology,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
May 2023, Journal of cutaneous pathology,
Hanako Ohmatsu, and Daniel Humme, and Nicholas Gulati, and Juana Gonzalez, and Markus Möbs, and Mayte Suárez-Fariñas, and Irma Cardinale, and Hiroshi Mitsui, and Emma Guttman-Yassky, and Wolfram Sterry, and James G Krueger
March 1996, Lancet (London, England),
Copied contents to your clipboard!